These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 8982736

  • 1. Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment.
    Lanes R, Gunczler P, Orta N, Bosquez M, Scovino R, Dominguez L, Esaa S, Weisinger JR.
    Horm Res; 1996; 46(6):263-8. PubMed ID: 8982736
    [Abstract] [Full Text] [Related]

  • 2. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 3. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG, Brown R, Baum M.
    Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
    [Abstract] [Full Text] [Related]

  • 4. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R.
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [Abstract] [Full Text] [Related]

  • 5. [The effect of recombinant human growth hormone on urea and creatinine kinetics and selected dialysis adequacy parameters in children with end-stage renal failure treated with peritoneal dialysis].
    Jedrzejowski A, Dyras P, Pańczyk-Tomaszewska M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pietrzyk JA, Gałazka B.
    Pol Merkur Lekarski; 2002 Sep; 13(75):191-5. PubMed ID: 12474568
    [Abstract] [Full Text] [Related]

  • 6. The effect of growth hormone on growth and blood urea levels in children with chronic renal failure.
    McMahon KA, Powell HR, Walker RG, Jones CL.
    J Paediatr Child Health; 1994 Jun; 30(3):230-3. PubMed ID: 8074908
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy.
    Lanes R, Gunczler P, Paoli M, Weisinger JR.
    Horm Res; 1995 Jun; 44(4):168-71. PubMed ID: 8522278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group.
    Fine RN, Brown DF, Kuntze J, Wooster P, Kohaut EE.
    J Pediatr; 1996 Dec; 129(6):883-91. PubMed ID: 8969731
    [Abstract] [Full Text] [Related]

  • 10. Predictors of the response to growth hormone in short prepubertal children post-renal transplant. German Study Group for Growth Hormone Treatment in Children Post Renal Transplantation Study Group Members.
    Tönshoff B, Haffner D, Albers N, Offner G, Mehls O.
    Br J Clin Pract Suppl; 1996 Aug; 85():34-7. PubMed ID: 8995027
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial.
    Hardin DS, Adams-Huet B, Brown D, Chatfield B, Dyson M, Ferkol T, Howenstine M, Prestidge C, Royce F, Rice J, Seilheimer DK, Steelman J, Shepherds R.
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4925-9. PubMed ID: 17018651
    [Abstract] [Full Text] [Related]

  • 12. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Wühl E, Haffner D, Tönshoff B, Mehls O.
    Kidney Int Suppl; 1993 Oct; 43():S76-82. PubMed ID: 8246375
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of growth hormone therapy in malnourished hemodialysis patients.
    Kotzmann H, Yilmaz N, Lercher P, Riedl M, Schmidt A, Schuster E, Kreuzer S, Geyer G, Frisch H, Hörl WH, Mayer G, Luger A.
    Kidney Int; 2001 Oct; 60(4):1578-85. PubMed ID: 11576376
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Recombinant human growth hormone treatment in short children with renal disease--our first experience].
    Spasojević-Dimitrijeva B, Kostić M, Peco-Antić A, Kruscić D, Cvetković M, Milosevski-Lomić G, Paripović D.
    Srp Arh Celok Lek; 2010 Oct; 138(3-4):197-203. PubMed ID: 20499500
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D, Alberti C, Alison M, Le Henaff L, Chevenne D, Boizeau P, Canal A, Ollivier G, Decostre V, Jacqz-Aigrain E, Carel JC, Czernichow P, Hogrel JY.
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
    Butenandt O, Lang G.
    J Pediatr Endocrinol Metab; 1997 Jul; 10(3):275-82. PubMed ID: 9388818
    [Abstract] [Full Text] [Related]

  • 20. Changes in bone matrix mineralization after growth hormone treatment in children and adolescents with chronic kidney failure treated by dialysis: a paired biopsy study.
    Nawrot-Wawrzyniak K, Misof BM, Roschger P, Pańczyk-Tomaszewska M, Ziółkowska H, Klaushofer K, Fratzl-Zelman N.
    Am J Kidney Dis; 2013 May; 61(5):767-77. PubMed ID: 23465957
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.